Author:
Shman Tatsiana V.,Fedasenka Uladzimir U.,Savitski Valery P.,Aleinikova Olga V.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference34 articles.
1. Ravindranath Y (2003) Recent advances in pediatric lymphoblastic and myeloid leukemia. Curr Opin Oncol 15:23–35
2. Langebrake C, Brinkmann I, Teigler-Schlegel A, Creutzig U, Griesinger F, Puhlmann U, Reinhardt D (2005) Immunophenotypic differences between diagnosis and relapse in childhood AML: implications for MRD monitoring. Cytometry B Clin Cytom 63:1–9
3. Zeleznikova T, Babusikova O (2006) The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia. Neoplasma 53:500–506
4. Baer MR, Stewart CC, Dodge RK, Leget G, Sule N, Mrozek K, Schiffer CA, Powell BL, Kolitz JE, Moore JO, Stone RM, Davey FR, Carroll AJ, Larson RA, Bloomfield CD (2001) High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood 97:3574–3580
5. Eisele L, Klein-Hitpass L, Chatzimanolis N, Opalka B, Boes T, Seeber S, Moritz T, Flasshove M (2007) Differential expression of drug resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia. Acta Haematol 117:8–15
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献